DE60110339D1 - Anti-Stress Zusammensetzung zum Einbringen in essbaren Träger - Google Patents

Anti-Stress Zusammensetzung zum Einbringen in essbaren Träger

Info

Publication number
DE60110339D1
DE60110339D1 DE60110339T DE60110339T DE60110339D1 DE 60110339 D1 DE60110339 D1 DE 60110339D1 DE 60110339 T DE60110339 T DE 60110339T DE 60110339 T DE60110339 T DE 60110339T DE 60110339 D1 DE60110339 D1 DE 60110339D1
Authority
DE
Germany
Prior art keywords
incorporation
edible carrier
stress composition
composition
calming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60110339T
Other languages
English (en)
Inventor
Robert Schwartz
Sylvie Chantereau
Jean-Christophe Anton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROBERT SCHWARTZ ILLKIRCH GRAFF
Original Assignee
ROBERT SCHWARTZ ILLKIRCH GRAFF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROBERT SCHWARTZ ILLKIRCH GRAFF filed Critical ROBERT SCHWARTZ ILLKIRCH GRAFF
Application granted granted Critical
Publication of DE60110339D1 publication Critical patent/DE60110339D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/46—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/48—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DE60110339T 2000-10-17 2001-02-27 Anti-Stress Zusammensetzung zum Einbringen in essbaren Träger Expired - Lifetime DE60110339D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0013298A FR2815227B1 (fr) 2000-10-17 2000-10-17 Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels

Publications (1)

Publication Number Publication Date
DE60110339D1 true DE60110339D1 (de) 2005-06-02

Family

ID=8855446

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60110339T Expired - Lifetime DE60110339D1 (de) 2000-10-17 2001-02-27 Anti-Stress Zusammensetzung zum Einbringen in essbaren Träger

Country Status (8)

Country Link
US (1) US6576252B2 (de)
EP (1) EP1198995B1 (de)
JP (1) JP2004511499A (de)
AT (1) ATE293893T1 (de)
AU (1) AU2002210666A1 (de)
DE (1) DE60110339D1 (de)
FR (1) FR2815227B1 (de)
WO (1) WO2002032234A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60025233T2 (de) 1999-10-01 2006-09-21 Johnson & Johnson Consumer Companies, Inc. Verfahren zur beruhigen von menschen unter verwendung von körperpflegemitteln
US20020146469A1 (en) * 2000-12-20 2002-10-10 Benjamin Wiegand Methods for reducing chronic stress in mammals
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US8142819B2 (en) * 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US7815944B2 (en) * 2001-06-20 2010-10-19 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity
US20040115290A1 (en) * 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
GB2411478A (en) 2002-01-29 2005-08-31 Johnson & Johnson Consumer Method of measuring the stress or relaxation level of a mammal
NZ539642A (en) * 2002-10-21 2007-01-26 Metaproteomics Llc Compositions containing extracts from hops in combination with a second component for treating inflammatory response
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
ATE421357T1 (de) * 2003-05-22 2009-02-15 Metaproteomics Llc Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität
DE112004001520B4 (de) * 2003-08-18 2008-04-10 Btg International Ltd. Verwendung eines Lipidglyzerids festgelegter Struktur zur Herstellung eines Medikamentes zur Behandlung der multiplen Sklerose
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
KR20070086079A (ko) * 2004-11-13 2007-08-27 메타프로테오믹스, 엘엘씨 사이클로옥시게나제-2의 억제를 나타내는 조성물
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
FR2885528A1 (fr) * 2005-05-13 2006-11-17 Persee Medica Composition utile pour traiter ou prevenir les troubles lies a un dereglement de l'horloge biologique
EP2248532A1 (de) * 2005-08-09 2010-11-10 Metaproteomics, LLP Proteinkinase-Modulation durch Hopfen- und Akazien-Produkte
CA2632684A1 (en) * 2005-12-09 2007-06-14 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
JP2009149523A (ja) * 2006-03-01 2009-07-09 Ucc Ueshima Coffee Co Ltd 免疫賦活剤とその製造方法
EP2023747A2 (de) * 2006-05-24 2009-02-18 DSMIP Assets B.V. 3,5-dihydroxy-2,4-cyclohexadienone und ihre derivate, sie enthaltende nahrungsmittelprodukte und angereicherte nahrungsmittel, und ihre verwendungen
US20080031982A1 (en) * 2006-06-20 2008-02-07 Metaproteomics, Llc Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
US20080051466A1 (en) * 2006-06-20 2008-02-28 Metaproteomics, Llc Isoalpha acid based protein kinase modulation cancer treatment
FR2912918A1 (fr) * 2007-02-27 2008-08-29 Persee Medica Soc Par Actions Utilisation d'acides gras polyinsatures et de flavonoides en tant qu'agents actifs dans une composition pour la prevention et/ou le traitement des cephalees.
MX2009010049A (es) * 2007-03-19 2010-03-04 Metaproteomics Llc Metodos y composiciones para promover la salud de huesos y articulaciones.
WO2008140842A1 (en) * 2007-05-11 2008-11-20 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
KR20100131969A (ko) * 2007-12-10 2010-12-16 메타프로테오믹스, 엘엘씨 암, 혈관신생 및 이와 관련된 염증 경로의 치환된 1,3-시클로펜타디온 다중-표적 단백질 키나아제 조절제
NZ588927A (en) * 2008-04-02 2013-02-22 Metaproteomics Llc Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
MX2010012171A (es) * 2008-05-21 2010-11-30 Stokely Van Camp Inc Bebida de recupercion a base de leche.
FR3031104B1 (fr) 2014-12-26 2017-01-06 Melchior Mat And Life Science France Composition pro-pheromonale apaisante pour les mammiferes
CN104815003B (zh) * 2015-05-04 2018-01-19 江苏天晟药业有限公司 一种高纯度啤酒花总黄酮的制备方法
CN104957714A (zh) * 2015-05-26 2015-10-07 高健铭 预防老年期脑神经元损伤的复方西洋参精油饮品
US20220288147A1 (en) * 2019-09-03 2022-09-15 Botalys Sa Ginseng composition and use thereof as a medicament
BE1027552B1 (fr) 2019-09-03 2021-03-30 Botalys Sa Composition du ginseng et son utilisation comme medicament pour le traitement ou la prevention du stress

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5554883A (en) * 1978-10-16 1980-04-22 Asama Kasei Kk Prevention of oxidation of food and drink
JPS59118053A (ja) * 1982-12-24 1984-07-07 Hayashibara Biochem Lab Inc 飲食物とその製造方法
IT1212792B (it) * 1983-11-30 1989-11-30 Egidio Aldo Moja Supplemento dietetico e alimento preconfezionato che lo contiene procedimento di preparazione e metodo di somministrazione
JPH06699B2 (ja) * 1984-08-11 1994-01-05 カネボウ食品株式会社 精神安定チユ−インガム
DE4029550A1 (de) * 1989-09-18 1991-03-28 Yoshio Tanaka Chlorella-algen und pilze enthaltende fettoel-nahrungsmittel und verfahren zur herstellung derselben
JP2852821B2 (ja) * 1991-03-29 1999-02-03 株式会社田村電機製作所 多機能電話装置
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
DE19612658A1 (de) * 1996-03-29 1997-10-02 Wacker Chemie Gmbh Verfahren zur Stabilisierung und Dispergierung von Pflanzenölen, die mehrfach ungesättigte Fettsäurereste enthalten, mittels gamma-Cyclodextrin sowie derart hergestellte Komplexe und ihre Verwendung
MY128092A (en) * 1996-07-10 2007-01-31 Manda Fermentation Co Ltd Fermented composition, method for manufacturing same, and applications thereof
US6080410A (en) * 1997-03-17 2000-06-27 Natrol, Inc. Method for reducing daily stress and anxiety in adults
US5922704A (en) * 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
US6077867A (en) * 1998-01-21 2000-06-20 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
JP2000255057A (ja) * 1999-03-11 2000-09-19 Konica Corp インクジェット記録装置

Also Published As

Publication number Publication date
AU2002210666A1 (en) 2002-04-29
US20030077313A1 (en) 2003-04-24
EP1198995A1 (de) 2002-04-24
EP1198995B1 (de) 2005-04-27
ATE293893T1 (de) 2005-05-15
FR2815227A1 (fr) 2002-04-19
US6576252B2 (en) 2003-06-10
FR2815227B1 (fr) 2003-04-11
JP2004511499A (ja) 2004-04-15
WO2002032234A1 (fr) 2002-04-25

Similar Documents

Publication Publication Date Title
ATE293893T1 (de) Anti-stress zusammensetzung zum einbringen in essbaren träger
AP2005003367A0 (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis.
NO20020055L (no) Blanding egnet for a danne en myk kapsel, samt spiselig myk kapsel.
HK1076991A1 (en) Nutritional supplement to treat macular degeneration
WO2002041706A3 (en) Bioactive compositions comprising conjugated linoleic acid glycerides and methods for producing bioactive conjugated linoleic acid
GR3015920T3 (en) Enzymatic method for reducing the amount of phosphorous-containing components in vegetable and animal oils.
NZ502584A (en) oil blend for use in a chocolate alternative containing palm kernel stearin, hydrogenated palm kernel stearin and hardened palm or cottonseed oil
TW200620615A (en) A substrate having a penetrating via and wiring connected to the penetrating via and a method for manufacturing the same
WO2001091765A3 (en) Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
ES2182919T3 (es) Dispositivo para la incontinencia urinaria..
AU7302801A (en) Improved methods of incorporating polyunsaturated fatty acids in milk
MY115995A (en) Method for decreasing viscosity by using gumacacia
PL1799204T3 (pl) Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6
MX238618B (es) Metodo para alterar en forma selectiva el nivel de grasa corporal, la eficiencia de conversion de alimento o la ganancia de peso.
WO2002010350A1 (fr) Technique de proliferation de cellules tueuses naturelles
WO2001091769A3 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
DE60331599D1 (de) Sonnenblumenöl, sonnenblumensamen und pflanzen mit modifizierter fettsäureverteilung im triacylglycerolmolekül
IES940674A2 (en) "An edible fat blend containing fish oil"
AU4426901A (en) Natural vegetable oil concentrated in unsaponifiable matters as food ingredient
DE69904046D1 (de) Verfahren zum füttern von ferkeln
DK1185161T3 (da) Fröolie med en modificeret fedtsyresammensætning
WO2001091768A3 (en) Compositions for treating brain disorders and enhancing brain function, containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2001091771A3 (en) Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2001091766A3 (en) Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
MX9206108A (es) Productos de soya con composicion mejorada de carbohidratos, metodo para su produccion y plantas de soya

Legal Events

Date Code Title Description
8332 No legal effect for de